World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
33756
World Ranking
7740
National Ranking
4030

Overview

Jeffrey E. Rubnitz is affiliated with St. Jude Children's Research Hospital in the United States. Their research primarily focuses on the fields of medicine with an emphasis on hematology, molecular biology, public health, oncology, and pediatrics.

The scientist's work encompasses a range of topics related to leukemia, particularly acute myeloid and acute lymphoblastic leukemia, as well as histone deacetylase inhibitors, epigenetics and DNA methylation, protein degradation, cancer genomics, and childhood cancer survivors' quality of life.

Frequent publication venues for Rubnitz include:

  • Blood
  • Blood Advances
  • Leukemia
  • Nature Communications
  • Cancer

Co-authors who have collaborated extensively with Rubnitz include:

  • Raul C. Ribeiro
  • Stanley Pounds
  • Hiroto Inaba
  • Jeffery M. Klco
  • Jatinder K. Lamba

Among the recent papers featuring Rubnitz as an author are:

  • "Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma," 2021, Cancer Discovery
  • "Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology," 2021, Journal of the National Comprehensive Cancer Network
  • "Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study," 2020, The Lancet Oncology
  • "Clinical Significance of Novel Subtypes of Acute Lymphoblastic Leukemia in the Context of Minimal Residual Disease-Directed Therapy," 2021, Blood Cancer Discovery
  • "How I treat pediatric acute myeloid leukemia," 2021, Blood

This publication record demonstrates a focus on leukemia treatment and therapeutic strategies, often addressing pediatric cases and refractory conditions.

Best Publications

  • Treating childhood acute lymphoblastic leukemia without cranial irradiation.

    Ching Hon Pui;Dario Campana;Deqing Pei;W. Paul Bowman

  • Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

    Elaine Coustan-Smith;Charles G. Mullighan;Mihaela Onciu;Frederick G. Behm

  • TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.

    Shurtleff Sa;Buijs A;Behm Fg;Rubnitz Je

  • NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia

    Jeffrey E. Rubnitz;Hiroto Inaba;Raul C. Ribeiro;Stanley Pounds

  • A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

    Rob Pieters;Martin Schrappe;Paola De Lorenzo;Ian Hann

  • Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.

    Elaine Coustan-Smith;Jose Sancho;Michael L. Hancock;James M. Boyett

  • Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

    Elaine Coustan-Smith;Frederick G. Behm;Frederick G. Behm;Joaquin Sanchez;James M. Boyett;James M. Boyett

  • Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial

    Jeffrey E. Rubnitz;Hiroto Inaba;Gary Dahl;Raul C. Ribeiro

  • Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

    Kirk R. Schultz;D. Jeanette Pullen;Harland N. Sather;Jonathan J. Shuster

  • Improved outcome for children with acute lymphoblastic leukemia: Results of Total Therapy Study XIIIB at St Jude Children's Research Hospital

    Ching Hon Pui;John T. Sandlund;Deqing Pei;Dario Campana

  • High incidence of secondary brain tumours after radiotherapy and antimetabolites

    Mary V. Relling;Mary V. Relling;Jeffrey E. Rubnitz;Jeffrey E. Rubnitz;Gaston K. Rivera;Gaston K. Rivera;James M. Boyett;James M. Boyett

  • Gene expression profiling of pediatric acute myelogenous leukemia.

    Mary E. Ross;Rami Mahfouz;Mihaela Onciu;Hsi Che Liu

  • Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

    Brian V. Balgobind;Susana C. Raimondi;Susana C. Raimondi;Jochen Harbott;Martin Zimmermann

  • Methotrexate-Induced Neurotoxicity and Leukoencephalopathy in Childhood Acute Lymphoblastic Leukemia

    Deepa Bhojwani;Noah D. Sabin;Deqing Pei;Jun J. Yang

  • Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia.

    Elaine Coustan-Smith;Jose Sancho;Frederick G. Behm;Michael L. Hancock

  • Cumulative Incidence of Secondary Neoplasms as a First Event After Childhood Acute Lymphoblastic Leukemia

    Nobuko Hijiya;Melissa M. Hudson;Shelly Lensing;Margie Zacher

  • Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia

    C.-H. Pui;C.-H. Pui;D. Pei;Jt T. Sandlund;Jt T. Sandlund;Rc C. Ribeiro;Rc C. Ribeiro

  • The minimum amount of homology required for homologous recombination in mammalian cells.

    J Rubnitz;S Subramani

  • Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia

    C. Michel Zwaan;Edward A. Kolb;Dirk Reinhardt;Jonas Abrahamsson

  • The genetic basis and cell of origin of mixed phenotype acute leukaemia

    Thomas B. Alexander;Thomas B. Alexander;Zhaohui Gu;Ilaria Iacobucci;Kirsten Dickerson

Frequent Co-Authors

Raul C. Ribeiro
Raul C. Ribeiro St. Jude Children's Research Hospital
Ching-Hon Pui
Ching-Hon Pui St. Jude Children's Research Hospital
Stanley Pounds
Stanley Pounds St. Jude Children's Research Hospital
John T. Sandlund
John T. Sandlund National Institutes of Health
Susana C. Raimondi
Susana C. Raimondi St. Jude Children's Research Hospital
James R. Downing
James R. Downing St. Jude Children's Research Hospital
Mary V. Relling
Mary V. Relling St. Jude Children's Research Hospital
Dario Campana
Dario Campana National University of Singapore
William E. Evans
William E. Evans St. Jude Children's Research Hospital
Scott C. Howard
Scott C. Howard University of Tennessee Health Science Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and complementary career pathways in healthcare can open up many opportunities alongside, or outside of, a traditional medical degree. For those interested in the administrative side, earning a degree in healthcare administration can lead to leadership positions in hospitals and clinics, handling vital decisions that impact patient care and overall efficiency.

Nursing professionals looking to advance can enroll in rn to np bridge programs, which allow registered nurses to become nurse practitioners—offering greater autonomy and responsibility in patient care. Meanwhile, those passionate about diet and health can pursue an online dietitian degree and build careers helping individuals manage wellbeing through nutrition.

For aspiring healthcare managers, enrolling in top cahme accredited mha programs is an excellent way to gain the advanced business skills needed for success in healthcare organizations. Many of these pathways are available fully online, offering flexibility for busy students or working professionals.

Best Scientists Citing Jeffrey E. Rubnitz

Trending Scientists